Meniere’s disease

98,681 views 15 slides Mar 25, 2014
Slide 1
Slide 1 of 15
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15

About This Presentation

No description available for this slideshow.


Slide Content

Meniere’s Disease By Mr. ASHOK BISHNOI Lecturer JINR

I n 1861 Prosper Meniere described a syndrome characterized by deafness, tinnitus, and episodic vertigo. He linked this condition to a disorder of the inner ear. Introduction:-

It is a syndrome characterized by a tried of symptoms; attacks of incapacitating vertigo, Sensorineural hearing loss & Tinnitus. Definition:-

It is usually occur in adulthood. Incidence:-

Etiology :- Unknown Risk factor:- Metabolic disorder Toxicity Allergies Emotional factor Circulatory disorder Anatomical abnormalities

Normal m emb ranous labyrinth Dilated membranous labyrinth in Meniere's disease ( Hydrops )

Due to etiological factors Over production of endolymph Excessive accumulation in inner ear Increase pressure Rupture of membrane Permanent loss auditory & vestibular function Pathophysiology :-

Periodic episodes vertigo or dizziness Tinnitus Sensorineural Hearing loss Fullness/pressure Nausea, vomiting, Diarrhea Increase pulse rate Diaphoresis Disorientation Clinical manifestation:

History Pattern of symptoms Association between hearing loss, tinnitus, and vertigo Physical examination Otoscopic examination Diagnostic evaluation:-

Rinne ( usually indicates that air conduction remains better than bone conduction) & weber test (Assess the bone conduction of sound with Tuning fork) Audiometric examination Electronystogmography (ENG) Audiometric brain stream response

Goal To Control vertigo Preserve hearing Stabilize tinnitus Nonpharmacological management:- Low sodium diet Labyrinthine compensatory exercise Avoidance of caffeine, nicotine & alcohal Management:-

Vestibular suppressants ( eg , meclizine ) Diuretics ( eg , hydrochlorothiazide) actually decrease the fluid pressure load in the inner ear . Vasodilator Anticholinergic Antiemetic eg . Trimethobenzamide 250 mg TDS Anti-inflammatory (steroids) Pharmacological management:-

Ototoxic ablation therapy ( Transtympanic injection of antibiotics that are toxic to inner ear ) Endolymhatic decompression Labyrinthectomy Surgical management:-

Partial or total loss of hearing. Constant tinnitus Permanent balance disability Fear, phobia Dehydration Decrease quality of life Trauma from falling Complication:-

Risk for fluid volume deficit R/T increase fluid output, altered intake. Risk for injury R/T altered mobility & vertigo. Altered auditory sensory perception R/T altered state of the ear. Anxiety R/t threat to changes health status . Body image disturb R/T vertigo . Nursing management:-
Tags